Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2017 Financial Results March 26, 2018
Titan Executes Agreement For Acquisition By Molteni Of Probuphine® In Europe And Other Select Territories March 21, 2018
European Medicines Agency Accepts Titan Pharmaceuticals' Marketing Authorization Application For Probuphine® November 27, 2017
Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2017 Financial Results November 3, 2017
Titan Pharmaceuticals Presents Non-Clinical Data From Liothyronine (L-T3) Implant Studies October 19, 2017
First Patient Treated With Titan Pharmaceuticals' Subdermal Implant For Parkinson's Disease October 11, 2017
